University of California San Francisco
Give to UCSF
COVID-19 Vaccine Fact Vs. Fiction: An Expert Weighs in on Common Fears
We posed the most common COVID-19 vaccine quandaries to Bryn Boslett, MD, an infectious disease expert who is leading the vaccination effort at UCSF. She explains why mRNA vaccines won’t affect your DNA, which allergies pose a risk, what 95 percent efficacy really means, and more.
Astonishing Animals That Illuminate Human Health
Giant lizards with superpowered hearts. Hairless rodents that don’t seem to age. Songbirds that babble like human babies. These and other scurrying, soaring, and slithering wonders are teaching scientists how our own bodies work – and how to fix them.
DNA Test Identifies Genetic Causes of Severe Fetal and Newborn Illness
A new study by University of California researchers shows the promise of high-throughput DNA-sequencing technologies to improve prenatal diagnosis and pregnancy outcomes for women who have experienced an abnormal prenatal ultrasound.
COVID-19 Has a Prolonged Effect for Many During Pregnancy
In the largest study to date of COVID-19 among non-hospitalized pregnant women, researchers analyzed the clinical course and outcomes of 594 women who tested positive for the SARS-CoV-2 virus during pregnancy.
Most Infants Are Well Even When Moms are Infected by COVID-19
Infants born to women with COVID-19 showed few adverse outcomes, according to the first report in the country of infant outcomes through eight weeks of age.
Maternal Stress During Pregnancy Linked to Infant Illness
Greater maternal stress during pregnancy is linked with significant increases in the number and variety of infant illness during the first year of life, independent of the level of stress after birth.
An Epidemic of Inequality
Communities of color have been hit hardest by COVID-19. Meanwhile, hundreds of thousands of people have taken to the streets in an outcry against police brutality. Both issues have roots in the same problem.
Pregnant Women with Fatty Liver Disease Face Worse Outcomes
Pregnant women with the metabolic condition known as non-alcoholic fatty liver disease have more than four times the risk of serious adverse maternal-fetal outcomes.
Microbiome Therapy Protects Against Recurrent Bacterial Vaginosis
A product containing healthy vaginal bacteria has proved effective against recurrent bacterial vaginosis (BV), an extremely common vaginal infection that is associated with preterm birth, HIV infection and problems with in vitro fertilization.
What We Know and Don’t Know About Coronavirus and Pregnancy
Pregnant women are at higher risk for many infections, but the risks of COVID-19 to mother and baby are not yet clear. UCSF experts share what we know and don’t know about COVID-19’s effects on pregnancy, the possibility of in utero transmission, and advice for pregnant women.
In Utero Stem Cell Transplants, Enzyme Replacement May Offer New Treatments for Deadly Metabolic Disorders
Administering stem cell or enzyme therapy in utero may be a path to alleviating some congenital diseases that often result in losing a pregnancy, according to a new study in mice by UCSF researchers. They showed that stem cells can enter the fetal brain during prenatal development and make up for cells that fail to make an essential protein.
